{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T13:44:47Z","timestamp":1772545487595,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00415-021-10788-z","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T11:03:17Z","timestamp":1631185397000},"page":"2099-2112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Early anticoagulation in atrial fibrillation-related acute ischaemic stroke: efficacy and safety profile"],"prefix":"10.1007","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6779-8975","authenticated-orcid":false,"given":"Joao","family":"Matos-Ribeiro","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8388-4312","authenticated-orcid":false,"given":"Paulo","family":"Castro-Chaves","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3902-2763","authenticated-orcid":false,"given":"Marta","family":"Oliveira-Ferreira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4208-7370","authenticated-orcid":false,"given":"Lu\u00edsa","family":"Fonseca","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7863-1991","authenticated-orcid":false,"given":"Mariana","family":"Pintalhao","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"10788_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/phar.2345","volume":"40","author":"MA Smythe","year":"2020","unstructured":"Smythe MA, Parker D, Garwood CL, Cuker A, Mess\u00e9 SR (2020) Timing of initiation of oral anticoagulation after acute ischemic stroke in patients with atrial fibrillation. Pharmacotherapy 40:55\u201371. https:\/\/doi.org\/10.1002\/phar.2345","journal-title":"Pharmacotherapy"},{"key":"10788_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s1474-4422(18)30356-9","volume":"18","author":"DJ Seiffge","year":"2019","unstructured":"Seiffge DJ, Werring DJ, Paciaroni M, Dawson J, Warach S, Milling TJ, Engelter ST et al (2019) Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. Lancet Neurol 18:117\u2013126. https:\/\/doi.org\/10.1016\/s1474-4422(18)30356-9","journal-title":"Lancet Neurol"},{"key":"10788_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2020","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, Boriani G et al (2020) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42:373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"10788_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11883-019-0790-x","volume":"21","author":"B Mac Grory","year":"2019","unstructured":"Mac Grory B, Flood S, Schrag M, Paciaroni M, Yaghi S (2019) Anticoagulation resumption after stroke from atrial fibrillation. Curr Atheroscler Rep 21:29. https:\/\/doi.org\/10.1007\/s11883-019-0790-x","journal-title":"Curr Atheroscler Rep"},{"key":"10788_CR5","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1161\/STROKEAHA.107.510321","volume":"39","author":"M Paciaroni","year":"2008","unstructured":"Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, Caso V et al (2008) Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome. Stroke 39:2249\u20132256. https:\/\/doi.org\/10.1161\/STROKEAHA.107.510321","journal-title":"Stroke"},{"key":"10788_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/2396987318787124","volume":"3","author":"D Munn","year":"2018","unstructured":"Munn D, Abdul-Rahim AH, Fischer U, Werring DJ, Robinson TG, Dawson J (2018) A survey of opinion: When to start oral anticoagulants in patients with acute ischaemic stroke and atrial fibrillation? Eur Stroke J 3:355\u2013360. https:\/\/doi.org\/10.1177\/2396987318787124","journal-title":"Eur Stroke J"},{"key":"10788_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105169","volume":"29","author":"I Rybinnik","year":"2020","unstructured":"Rybinnik I, Wong S, Mehta D, Leker RR, Mullen MT, Mess\u00e9 SR, Kasner SE et al (2020) Anticoagulation choice and timing in stroke due to atrial fibrillation: a survey of us stroke specialists (ACT-SAFe). J Stroke Cerebrovasc Dis 29:105169. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105169","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10788_CR8","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1161\/01.STR.14.5.688","volume":"14","author":"RG Hart","year":"1983","unstructured":"Hart RG, Coull BM, Hart D (1983) Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study. Stroke 14:688\u2013693. https:\/\/doi.org\/10.1161\/01.STR.14.5.688","journal-title":"Stroke"},{"key":"10788_CR9","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J et al (2019) Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke 50:e344\u2013e418. https:\/\/doi.org\/10.1161\/STR.0000000000000211","journal-title":"Stroke"},{"key":"10788_CR10","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","volume":"39","author":"J Steffel","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Haeusler KG et al (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 39:1330\u20131393. https:\/\/doi.org\/10.1093\/eurheartj\/ehy136","journal-title":"Eur Heart J"},{"key":"10788_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.7861\/clinmedicine.17-2-154","volume":"17","author":"AG Rudd","year":"2017","unstructured":"Rudd AG, Bowen A, Young GR, James MA (2017) The latest national clinical guideline for stroke. Clin Med (Lond) 17:154\u2013155. https:\/\/doi.org\/10.7861\/clinmedicine.17-2-154","journal-title":"Clin Med (Lond)"},{"key":"10788_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.030042","author":"AJ Labovitz","year":"2021","unstructured":"Labovitz AJ, Rose DZ, Fradley MG, Meriwether JN, Renati S, Martin R, Kasprowicz T et al (2021) Early apixaban use following stroke in patients with atrial fibrillation. Stroke. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030042","journal-title":"Stroke"},{"key":"10788_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams","year":"1993","unstructured":"Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35\u201341. https:\/\/doi.org\/10.1161\/01.STR.24.1.35","journal-title":"Stroke"},{"key":"10788_CR14","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/0140-6736(91)93206-o","volume":"337","author":"J Bamford","year":"1991","unstructured":"Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521\u20131526. https:\/\/doi.org\/10.1016\/0140-6736(91)93206-o","journal-title":"Lancet"},{"key":"10788_CR15","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1161\/strokeaha.119.026448","volume":"50","author":"E Drouard-de Rousiers","year":"2019","unstructured":"Drouard-de Rousiers E, Lucas L, Richard S, Consoli A, Mazighi M, Labreuche J, Kyheng M et al (2019) Impact of reperfusion for nonagenarians treated by mechanical thrombectomy: insights from the ETIS registry. Stroke 50:3164\u20133169. https:\/\/doi.org\/10.1161\/strokeaha.119.026448","journal-title":"Stroke"},{"key":"10788_CR16","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/STROKEAHA.115.010049","volume":"46","author":"K Rv","year":"2015","unstructured":"Rv K, Broderick JP, Campbell BCV, Demchuk A, Goyal M, Hill MD, Treurniet KM et al (2015) The Heidelberg bleeding classification. Stroke 46:2981\u20132986. https:\/\/doi.org\/10.1161\/STROKEAHA.115.010049","journal-title":"Stroke"},{"key":"10788_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692\u2013694. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x","journal-title":"J Thromb Haemost"},{"key":"10788_CR18","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/jth.13140","volume":"13","author":"S Kaatz","year":"2015","unstructured":"Kaatz S, Ahmad D, Spyropoulos AC, Schulman S (2015) Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 13:2119\u20132126. https:\/\/doi.org\/10.1111\/jth.13140","journal-title":"J Thromb Haemost"},{"key":"10788_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.118.010133","volume":"7","author":"M Paciaroni","year":"2018","unstructured":"Paciaroni M, Bandini F, Agnelli G, Tsivgoulis G, Yaghi S, Furie KL, Tadi P et al (2018) Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: time to initiation of oral anticoagulant therapy and outcomes. J Am Heart Assoc 7:e010133. https:\/\/doi.org\/10.1161\/jaha.118.010133","journal-title":"J Am Heart Assoc"},{"key":"10788_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10557-008-6122-y","volume":"22","author":"A Beri","year":"2008","unstructured":"Beri A, Punnam SR (2008) Anticoagulation in patients with acute ischemic stroke and atrial fibrillation\u2013a balance of risks and benefits. Cardiovasc Drugs Ther 22:419\u2013425. https:\/\/doi.org\/10.1007\/s10557-008-6122-y","journal-title":"Cardiovasc Drugs Ther"},{"key":"10788_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/VHRM.S81807","volume":"12","author":"K Hahne","year":"2016","unstructured":"Hahne K, M\u00f6nnig G, Samol A (2016) Atrial fibrillation and silent stroke: links, risks, and challenges. Vasc Health Risk Manag 12:65\u201374. https:\/\/doi.org\/10.2147\/VHRM.S81807","journal-title":"Vasc Health Risk Manag"},{"key":"10788_CR22","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jacc.2018.12.039","volume":"73","author":"D Conen","year":"2019","unstructured":"Conen D, Rodondi N, M\u00fcller A, Beer JH, Ammann P, Moschovitis G, Auricchio A et al (2019) Relationships of overt and silent brain lesions with cognitive function in patients with atrial fibrillation. J Am Coll Cardiol 73:989\u2013999. https:\/\/doi.org\/10.1016\/j.jacc.2018.12.039","journal-title":"J Am Coll Cardiol"},{"key":"10788_CR23","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1161\/strokeaha.110.602235","volume":"42","author":"N Hannon","year":"2011","unstructured":"Hannon N, Callaly E, Moore A, D NC, Sheehan O, Marnane M, Merwick A, et al (2011) Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: a population study. Stroke 42:2503\u20132508. https:\/\/doi.org\/10.1161\/strokeaha.110.602235","journal-title":"Stroke"},{"key":"10788_CR24","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jama.2016.13647","volume":"316","author":"JL Saver","year":"2016","unstructured":"Saver JL, Goyal M, van der Lugt A, Menon BK, Majoie CB, Dippel DW, Campbell BC et al (2016) Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 316:1279\u20131288. https:\/\/doi.org\/10.1001\/jama.2016.13647","journal-title":"JAMA"},{"key":"10788_CR25","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","volume":"46","author":"M Paciaroni","year":"2015","unstructured":"Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S, Rueckert C et al (2015) Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation. Stroke 46:2175\u20132182. https:\/\/doi.org\/10.1161\/STROKEAHA.115.008891","journal-title":"Stroke"},{"key":"10788_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.117.007034","author":"M Paciaroni","year":"2017","unstructured":"Paciaroni M, Agnelli G, Falocci N, Tsivgoulis G, Vadikolias K, Liantinioti C, Chondrogianni M et al (2017) Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/jaha.117.007034","journal-title":"J Am Heart Assoc"},{"key":"10788_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212354","volume":"14","author":"M Yasaka","year":"2019","unstructured":"Yasaka M, Minematsu K, Toyoda K, Mori E, Hirano T, Hamasaki T, Yamagami H et al (2019) Rivaroxaban administration after acute ischemic stroke: the RELAXED study. PLoS ONE 14:e0212354. https:\/\/doi.org\/10.1371\/journal.pone.0212354","journal-title":"PLoS ONE"},{"key":"10788_CR28","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaneurol.2017.2161","volume":"74","author":"KS Hong","year":"2017","unstructured":"Hong KS, Kwon SU, Lee SH, Lee JS, Kim YJ, Song TJ, Kim YD et al (2017) Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation-related mild ischemic stroke: a randomized clinical trial. JAMA Neurol 74:1206\u20131215. https:\/\/doi.org\/10.1001\/jamaneurol.2017.2161","journal-title":"JAMA Neurol"},{"key":"10788_CR29","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1212\/WNL.0000000000003283","volume":"87","author":"DJ Seiffge","year":"2016","unstructured":"Seiffge DJ, Traenka C, Polymeris A, Hert L, Peters N, Lyrer P, Engelter ST et al (2016) Early start of DOAC after ischemic stroke. Neurology 87:1856. https:\/\/doi.org\/10.1212\/WNL.0000000000003283","journal-title":"Neurology"},{"key":"10788_CR30","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/ene.12577","volume":"22","author":"AH Abdul-Rahim","year":"2015","unstructured":"Abdul-Rahim AH, Fulton RL, Frank B, Tatlisumak T, Paciaroni M, Caso V, Diener HC et al (2015) Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA. Eur J Neurol 22:1048\u20131055. https:\/\/doi.org\/10.1111\/ene.12577","journal-title":"Eur J Neurol"},{"key":"10788_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/jnnp-2018-318890","volume":"90","author":"D Wilson","year":"2019","unstructured":"Wilson D, Ambler G, Banerjee G, Shakeshaft C, Cohen H, Yousry TA, Al-Shahi Salman R et al (2019) Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study. J Neurol Neurosurg Psychiatry 90:320\u2013325. https:\/\/doi.org\/10.1136\/jnnp-2018-318890","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10788_CR32","doi-asserted-by":"publisher","first-page":"030006052096234","DOI":"10.1177\/0300060520962347","volume":"48","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wang J, Zeng W-z, Lyu Q-s (2020) Nonlinear relationship between serum total bilirubin levels and initial ischemic stroke in patients with non-valvular atrial fibrillation. J Int Med Res 48:0300060520962347. https:\/\/doi.org\/10.1177\/0300060520962347","journal-title":"J Int Med Res"},{"key":"10788_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/svn-2019-000289","volume":"5","author":"X Wang","year":"2020","unstructured":"Wang X, Wu D, Zhong P (2020) Serum bilirubin and ischaemic stroke: a review of literature. Stroke Vasc Neurol 5:198\u2013204. https:\/\/doi.org\/10.1136\/svn-2019-000289","journal-title":"Stroke Vasc Neurol"},{"key":"10788_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12933-020-01005-8","volume":"19","author":"YH Chan","year":"2020","unstructured":"Chan YH, Chuang C, Chan CC, Lee HF, Huang YC, Huang YT, Chang SH et al (2020) Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation. Cardiovasc Diabetol 19:30. https:\/\/doi.org\/10.1186\/s12933-020-01005-8","journal-title":"Cardiovasc Diabetol"},{"key":"10788_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/00000441-199808000-00005","volume":"316","author":"AL Weigert","year":"1998","unstructured":"Weigert AL, Schafer AI (1998) Uremic bleeding: pathogenesis and therapy. Am J Med Sci 316:94\u2013104. https:\/\/doi.org\/10.1097\/00000441-199808000-00005","journal-title":"Am J Med Sci"},{"key":"10788_CR36","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1161\/strokeaha.118.022856","volume":"50","author":"R Altavilla","year":"2019","unstructured":"Altavilla R, Caso V, Bandini F, Agnelli G, Tsivgoulis G, Yaghi S, Furie KL et al (2019) Anticoagulation after stroke in patients with atrial fibrillation. Stroke 50:2093\u20132100. https:\/\/doi.org\/10.1161\/strokeaha.118.022856","journal-title":"Stroke"},{"key":"10788_CR37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/2396987319841187","volume":"4","author":"CJ Klijn","year":"2019","unstructured":"Klijn CJ, Paciaroni M, Berge E, Korompoki E, K\u00f5rv J, Lal A, Putaala J et al (2019) Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: a European Stroke Organisation guideline. Eur Stroke J 4:198\u2013223. https:\/\/doi.org\/10.1177\/2396987319841187","journal-title":"Eur Stroke J"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10788-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10788-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10788-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T16:12:12Z","timestamp":1647965532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10788-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10788"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10788-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"12 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This research study complies with the principles outlined in the 1964 Declaration of Helsinki, including its later amendments, and was approved by the Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o\/Faculdade de Medicina da Universidade do Porto\u2019s Ethics Committee (15th December 2020\/No. 435\/20). The manuscript does not contain patient data that might disclose the identity of the subjects under study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}